Work

A Phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time

Year: 1997

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/(sici)1097-0142(19970501)79:9<1703::aid-cncr10>3.0.co;2-1

Authors: Hans-Peter Schmid, Rudolf Maibach, Juerg Bernhard, Franz Hering, Silvia Hanselmann, Heidi Gusset, Rudolf Morant, Dietegen Pestalozzi, Monica Castiglione

Institutions: University of Bern, University Hospital of Bern

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1973143779

FWCI: 1.132

Cites: 18

Cited by: 25

Related to: 10